40 results
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
9 May 24
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:07am
. Diabetes and hypertension are responsible for approximately two-thirds of CKD cases. Early detection and treatment can often keep CKD from getting worse … hypertension and CKD. Lorundrostat was designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for its production
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
, responsible for overseeing such composite currency;
the designation of the currency, currencies or currency units in which payment of principal … with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail to each holder of the securities
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
and chairman of the board of directors in recognition of the differences between the two roles. The chief executive officer is responsible for setting … is responsible for assessing whether any of our compensation policies or programs has the potential to encourage excessive risk-taking. The nominating
8-K
EX-99.1
a0tf3hc
21 Mar 24
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:43am
S-3
EX-1.2
kd2n2vlj1z 04ioge
21 Mar 24
Shelf registration
7:30am
S-3
EX-4.3
zkfesv1ydueov5sqfztr
21 Mar 24
Shelf registration
7:30am
S-3
6b3gy602g8 ra6p
21 Mar 24
Shelf registration
7:30am
8-K
EX-10.1
mo662h
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
8-K
EX-4.1
iz0d8g z1
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
8-K
EX-99
i79qzeb18mguyqo
4 Jan 24
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
4:10pm
8-K
EX-99.1
yt35g9f
22 Dec 23
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
9:04am
8-K
EX-99.1
zkgg1qqam0 61l8i26
13 Nov 23
Regulation FD Disclosure
8:20am